| Serial Number | 97575104 |
| Word Mark | LION |
| Filing Date | Thursday, September 1, 2022 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Wednesday, February 28, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Medical, biological, and pharmaceutical preparations for the treatment of cancer, infectious diseases, and rare and orphan diseases; Therapeutic preparations in the nature of vaccines or nucleic acid, protein or small-molecule medicines, delivered via intramuscular injections, intravenous injections, inhalation, transdermal, intradermal, or intranasal methods, for the treatment of cancer, infectious diseases, and rare and orphan diseases; Immunotherapeutics, namely, pharmaceutical preparations in the nature of vaccines and nucleic acid, protein or small-molecule medicines for the treatment of cancer, infectious diseases, and rare and orphan diseases; Nanoparticles and nanoparticle formulations in the nature of active pharmaceutical ingredient delivery agents in the form of nanoparticles that facilitate the delivery of medical, biological, pharmaceutical, and therapeutic preparations for the treatment of cancer, infectious diseases, and rare and orphan diseases; Pharmaceutical preparations, namely, lipid-enabled drug delivery systems for nucleic acid, protein or small-molecule medicines comprising small interfering RNA, messenger RNA, antisense, microRNA, DNA, or cDNA oligotherapeutic, protein therapeutic agents, or small molecules to enable the targeting of any gene in the human genome, modulating immune response, or vaccination, sold to pharmaceutical companies as an integral component for use in the further manufacture of pharmaceutical preparations for the treatment of a wide variety of diseases, including cancer, infectious diseases, and rare and orphan diseases; Vaccines; Veterinary vaccines |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 9, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, January 1, 1970 |
| First Use In Commerce Date | Thursday, January 1, 1970 |
| Party Name | HDT Bio Corp. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, US 98501 |
| Event Date | Event Description |
| Monday, September 5, 2022 | NEW APPLICATION ENTERED |
| Friday, September 9, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, June 17, 2023 | ASSIGNED TO EXAMINER |
| Thursday, July 13, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, July 13, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, July 13, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, October 12, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, October 12, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Saturday, January 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, January 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 15, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 26, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, April 26, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, February 28, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, February 28, 2024 | FINAL REFUSAL WRITTEN |
| Wednesday, February 28, 2024 | FINAL REFUSAL E-MAILED |